WARSAW, Ind., Dec. 8, 2011 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a global leader in musculoskeletal care, today announced the availability of its CLS® Brevius™ Hip Stem with Kinectiv® Technology in the United States. This new technology enables surgeons to better match patients' individual anatomies with modular neck options designed for independent, intraoperative adjustments.
"Following its introduction in Europe earlier this year, we have received excellent clinical feedback on the performance of the new CLS Brevius Stem," said Jeff McCaulley, President, Zimmer Reconstructive. "Incorporating Kinectiv Technology to this new stem provides unparalleled intraoperative flexibility for our customers to restore their patients' anatomies."
The new hip stem is based on the Zimmer CLS Spotorno® Stem, one of the most reliable implants worldwide with more than 25 years of clinical use. Since its introduction in the 1980s, the CLS Spotorno Stem has been used in more than 560,000 total hip arthroplasty procedures around the world. The CLS Spotorno Stem is characterized by excellent primary and rotational stability in uncemented total hip arthroplasty.
Building on this history of clinical success, the new CLS Brevius Hip Stem provides greater intraoperative flexibility with the addition of Kinectiv Technology. Kinectiv Technology offers a wide array of head center locations, enabling independent, intraoperative control of leg length, offset and version for a more accurate restoration of the patient's natural anatomy. The CLS Brevius Stem with Kinectiv Technology is shorter than conventional stems, providing greater bone conservation compared with the original CLS Spot
|SOURCE Zimmer Holdings, Inc.|
Copyright©2010 PR Newswire.
All rights reserved